MAAT INDEX

CLAIM #58734 · UnitedHealth Group Incorporated (UNH) · 2024Q2 earnings call · Jul 16, 2024 · due Dec 31, 2025

So, as we think about margins in the MA business and as it relates to our bid, I think we've talked about the consistent approach to how we plan margins. And we maintain -- continue to maintain that and we're operating comfortably within that margin range as we have in the past and as we're planning in 2025.

Tim Noel · Executive

CANNOT_DETERMINE
resolved by a revision, graded at the moved level · official band 5 percent
Committed
we're operating comfortably within that margin range as we have in the past and as we're planning in 2025
Reported
So I think kind of the two to two and a half percent range, and I'm talking about kinda all broad-based.

In context

s well as any potential market share gains? Andrew Witty: Hey, Josh, thanks so much. I'm going to ask Tim Noel to address the first part of your question. On the second part, you're not going to be surprised. I'm going to defer from making any predictions about next year. It's still a little early. We'd like to see where everybody else plays out in this cycle. I think we [also are] (ph) in the 2024 cycle. Ultimately, the way growth plays out in the marketplace depends on how everybody bids, not just on how you bid. And it only takes one bid to be kind of out of expectation to completely distort your view of how things could play out. So, just going to defer a little bit on that one, but on the first point, Tim, I'd love you to make a few comments. Tim Noel: Thanks, Josh, for the question. So, as we think about margins in the MA business and as it relates to our bid, I think we've talked about the consistent approach to how we plan margins. And we maintain -- continue to maintain that and we're operating comfortably within that margin range as we have in the past and as we're planning in 2025. And then when I think about our pricing approach for 2025, as Andrew mentioned, too early to get into a lot of specifics as CMS is reviewing those bids right now. But we're in a posture and how we've priced those products as we'll be comfortable with whatever growth is the outcome of the products that we bring to marketplace in 2025. Andrew Witty: Great. Thanks so much, Tim. And, Josh, appreciate the question. Next question, please. Operator: We'll go next to Stephen Baxter with Wells Fargo. Stephen Baxter: Yes. Hi. Thanks. Can you speak in a little greater detail about your expectation that the Medicaid pressure starts to subside in the second half of the year? I guess specifically, can you maybe speak to what you actually know about rates today, either draft or finalized, versus perhaps

Verify independently

SEC filings for UNH · Claim quote is verbatim from the 2024Q2 earnings call.